Business
Result of Open Offer - full take up
Result of Open Offer - full take up.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \n \n RNS Number : 3146S\n Omega Diagnostics Group PLC\n 08 July 2020\n \n \n \n \n \n \n \n THIS ANNOUNCEMENT AND THE INFORMATION IN IT, IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION.\n \n \n \n \n \n FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.\n \n \n \n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO 596/2014, AS AMENDED.\n \n \n \n \n \n OMEGA DIAGNOSTICS GROUP PLC\n \n \n (\"Omega\" or the \"Company\" or the \"Group\")\n \n \n \n \n \n Result of Open Offer - full take up\n \n \n \n \n \n Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, is pleased to announce the results of its Open Offer.\n \n \n \n \n \n On 19 June 2020, Omega announced its intention to raise gross proceeds of up to £11.0 million by way of a Placing, Subscription and Open Offer (together the \"Fundraising\"), all at an issue price of 40 pence per New Ordinary Share. \n \n \n A total of 27,531,100 New Ordinary Shares will be issued at the Issue Price (subject to the conditions noted below), of which, 7,515,350 New Ordinary Shares have already been admitted to trading pursuant to the First Placing on 25 June 2020, 12,434,650 New Ordinary Shares will be issued pursuant to the Second Placing, 50,000 New Ordinary Shares will be issued pursuant to the Subscription and 7,531,100 New Ordinary Shares will be issued pursuant to the Open Offer (the \"Open Offer Shares\"). This brings the gross proceeds of the Fundraising to £11 million before expenses.\n \n \n \n \n \n The Open Offer closed for acceptances at 11.00 a.m. on 7 July 2020. The Company has received valid acceptances from Qualifying Shareholders in respect of their Basic Entitlements in respect of 4,089,048 New Ordinary Shares, representing approximately 54 per cent. of the Open Offer Shares. In addition, the Company has received applications from Qualifying Shareholders under the Excess...